Beijing Luzhu Biotechnology Co., Ltd. (02480) released its Monthly Return for the period ended 31 January 2026, showing no change in share capital compared to the preceding month. The total authorized (or issued) share capital remained RMB202,449,032, comprising 202,449,032 shares at RMB1 par value each.

The number of issued shares excluding treasury shares stayed at 198,913,232, while treasury shares remained at 3,535,800. The public float of the H shares satisfied the 25% minimum requirement, and no new share options, warrants, convertibles, or other arrangements to issue shares were reported. The return also confirmed compliance with all relevant listing rules and regulatory requirements.